Prise en charge préhospitalière de l'infarctus du myocarde évolutif 2e Conférence d'experts en médecine d'urgence de la région Sud-Est

Annales Francaises d'Anesthesie et de Reanimation

Volumn 16, Issue 5, 1997, Pages 541-548

  Bonnet, J L ^a   Domergue, R ^a   Martin, C ^b   Ait Abbas, ^c   Ahmad, Ali ^c   Ambrosi, ^c   Arzalier, ^c   Auffray, ^c   Barreau, ^c   Bettayed, ^c   Bidet, ^c   Bonal, ^c   Bonnet, ^c   Bory, ^c   Carli, ^c   Carpentier, ^c   Canavy, ^c   De La Coussaye, ^c   Deloffre, ^c   Djiane, ^c   Domergue, ^c   Dubouloz, ^c   Dubuisson, ^c   Ebagosti, ^c   Farisse, ^c   Fauzee, ^c   Ferracci, ^c   Fockenier, ^c   Fourcade, ^c   Giacomoni, ^c   Gonzales, ^c   Habib, ^c   Hamon, ^c   Man, ^c   Hirsch, ^c   Jaffier, ^c   Jammes, ^c   Jouve, ^c   Kiegel, ^c   Krajevitch, ^c   Lambert, ^c   Lanaspre, ^c   Latour, ^c   Legrand, ^c   Letallec, ^c   Marble, ^c   Melandry, ^c   Mescam, ^c   Metge, ^c   Meyran, ^c   Paganelli, ^c   Panagides, ^c   Peyre, ^c   Pons, ^c   Remond, ^c   Rocamora, ^c   Rostini, ^c   Sans, ^c   Splaulding, ^c   Sunda, ^c   Taleb, ^c   Valeri, ^c   more..

^a TIMONE HOSPITAL   (France)

^b HÔPITAL NORD   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; VASODILATOR AGENT;

ADULT; AGED; AORTA ANEURYSM; CARDIOGENIC SHOCK; CARDIOVERSION; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIFFERENTIAL DIAGNOSIS; DISSECTING ANEURYSM; DRUG CONTRAINDICATION; ELECTROCARDIOGRAPHY; EMERGENCY HEALTH SERVICE; FIBRINOLYTIC THERAPY; FIRST AID; FLUID THERAPY; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE REPERFUSION; HOSPITAL; HUMAN; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATIENT CARE; PATIENT TRANSPORT; REPERFUSION INJURY;

ADULT; AGED; ANALGESICS; ANEURYSM, DISSECTING; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; AORTIC ANEURYSM; ARRHYTHMIA; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; FIBRINOLYTIC AGENTS; FIRST AID; FLUID THERAPY; HOSPITALS, SPECIAL; HUMANS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; NITROGLYCERIN; PATIENT CARE TEAM; PATIENT TRANSFER; SHOCK, CARDIOGENIC; THROMBOLYTIC THERAPY; VASODILATOR AGENTS;

EID: 0031300976     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(97)83350-3     Document Type: Article

References (34)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397-40.
2. ISIS 2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction; ISIS-2. Lancet 1988;ii:349-60
3. Wilcox RG, Von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Lancet 1988;ii:525-30
4. ISAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity and infarct size at 21 days. N Engl J Med 1986;314:1465-71
5. AIMS Trial Study Group. Effects of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988;i:842-7
6. Rossi P, Bolognese L on behalf of Urochinasi per via Sistemica nell'Infarto Miocardico (USIM) Collaborative Group. Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction. Am J Cordiol 1991;68:585-92
7. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. ISIS-3: a randomised trial of streptokinase vs tissue plasminogen activator vs anistreptase and of aspirin plus heparin vs heparin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992;339:753-70
8. EMERAS (Estudio Multicentrico Estreptoquinasa Republicas de America del sur) Collaborative Group. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 1993;342:767-72
9. LATE Study Group. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993;342:759-66
10. Fibrinolytic Therapy Trialists'(FTT) collaborative group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1,000 patients. Lancet 1994;343:311-22
11. Verstraete M, Bleifeld W, Brower RW, Charbonnier B, Collen D, de Bono DP et al. Double-blind randomised trial of intravenous tissue-type plasminogen activator versus placebo in acute myocardial infarction (ECSG-1). Lancet 1985;2:965-9
12. Gruppo Italiano per lo Studio della Sopravivenza nell'Infarto Miocardico (GISSI-2). A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 14,490 patients with acute myocardial infarction. Lancet 1990;336:65-71
13. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82
14. Weaver WD, Cerqueira M, Hallstrom AP, Litwin PA, Martin JS, Kudenchuk PJ et al for the MITI Project Group. Early treatment with thrombolytic therapy: Results from the Myocardial Infarction, Triage and Intervention Pre-Hospital Trial. JAMA 1993;270: 1211-6
15. The EMIP Group: Pre-hospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993;329: 383-9
16. Chesbro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase 1: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987;76:142-54
17. Verstraete M, Bernard R, Bory M, Brower RW, Collen D, de Bono DP et al. Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction (ECSG-2). Lancet 1985;1:842-7
18. The GUSTO angiographic investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615-22
19. Hsia J, Hamilton WP, Kleiman N, Roberts R, Chitman BR, Ross AM. A comparison between heparin and low dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1990;323:1433-7
20. Bleich SD, Nichols TC, Schumacher RR, Cooke DH, Tate DA, Teichman SL. Effect of heparin on coronary arterial patency after thrombolysis with plasminogen activator in acute myocardial infarction. Am J Cardiol 1990;66:1412-7
21. Arnout J, Simoons M, de Bono D, Rapold H, Collen D, Verstraete M. Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (t-PA). J Am Coll Cardiol 1992;20: 513-9
22. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J et al for the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thromboly tic therapy for acute myocardial infarction. W Engl J Med 1993; 328:673-9
23. Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4
24. De Boer MJ, Suryapranata H, Hoorntje JCA, Reiffers S, Liem AL, Miedema K et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction. Circulation 1994;90:753-61
25. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ et al for the Mayo coronary care unit and catheterisation laboratory. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993;328:685-91
26. Ribeiro EE, Silva LA, Carneiro R, d'Oliveira LG, Casques A, Amino JG et al. Randomized trial of direct coronary angioplasty versus inravenous streptokinase in acute myocardial infarction. J Am Coll Cordiol 1993;22:376-80
27. Berger PB, Bell M, Holmes DR, Gersh BJ, Hopfenspirger M, Gibbons R.Time to reperfusion with direct coronary angioplasty and thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1994;73:231-6
28. Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl JMed 1987;317:581-8
29. Simoons ML, Arnold AER, Betriu A, de Bono DP, Col J, Dougherty FC et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction. No additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988;i:197-203
30. The TIMI Research Group. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. JAMA 1988;260:2849-58
31. O'Neil W, Weintraub R, Grines CL, Meany TB, Brodie BR, Freidman HZ et al. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction. Circulation 1992;86:1710-7
32. Ellis SG, Da Silva ER, Heyndricks GR, Talley JD, Cernigliaro C, Steg G et al. Final results of the randomized RESCUE study evaluating PTCA after failed thrombolysis for patients with anterior myocardial infarction. Circulation 1993;88:1-106
33. Califf RM, Topol EJ, Stack RS, Ellis SG, George BS, Kereiakes DJ et al for the TAMI study group. Evaluation of combination thrombolytic therapy and timing of cardiac catheterisation in acute myocardial infarction. Circulation 1991;83:1543-56
34. The TIMI Study group. Comparison of invasive and conservative strategies following intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II Trial. N Engl Med 1989;320:618-28